Recombinant Human KLKB1/Plasma kallikrein

Recombinant Human KLKB1/Plasma kallikrein

价格: ¥840 - 2520

品牌:近岸蛋白(Novoprotein) 品牌认证

货号:CJ20

收藏

产品详情

相关推荐

英文名 :Recombinant Human KLKB1/Plasma kallikrein

规格 :10ug/50ug/500ug/1mg

Recombinant Human KLKB1/Plasma kallikrein  (CJ20)

 

产品说明(Description)

Recombinant Human Plasma kallikrein is produced by our Mammalian expression system and the target gene encoding Gly20-Ala638 is expressed with a 6His tag at the C-terminus. 

Accession #: P03952

Known as: Plasma kallikrein;Fletcher factor;Kininogenin;Plasma prekallikrein;KLKB1;KLK3

 

制剂(Formulation)

Supplied as a 0.2 μm filtered solution of 20mM TrisHCl,150mM NaCl,10% Glycerol,pH8.0.

 

质量控制(Quality Control) 

 

Purity:            Greater than 95% as determined by reducing SDS-PAGE.    

Endotoxin:    Less than 0.1 ng/ug (1 EU/ug) as determined by LAL test.

 

 

运输(Shipping)

The product is shipped on dry ice/polar packs. 
Upon receipt, store it immediately at the temperature listed below.

 

保存(Storage)

Store at ≤-70°C, stable for 6 months after receipt.
Store at ≤-70°C, stable for 3 months under sterile conditions after opening. 
Please minimize freeze-thaw cycles.     

 

背景(Background)

KLKB1 is a 638 amino acids protein that belongs to the peptidase S1 family and plasma kallikrein subfamily. It contains a peptidase S1 domain and four apple domains. The enzyme cleaves Lys-Arg and Arg-Ser bonds. It activates, in a reciprocal reaction, factor XII after its binding to a negatively charged surface. It also releases bradykinin from HMW kininogen and may also play a role in the renin-angiotensin system by converting prorenin into renin. It participates in the surface-dependent activation of blood coagulation, fibrinolysis, kinin generation and inflammation.Plasma prekallikrein deficiency causes a prolonged activated partial thromboplastin time in patients.

 

电泳(SDS-PAGE)

 

参考文献(References)

Plasma kallikrein cleaves and inactivates apelin-17: Palmitoyl- and PEG-extended apelin-17 analogs as metabolically stable blood pressure-lowering agents[J]. ConradFischer. et al. European Journal of Medicinal Chemistry. 2019.

 

FOR RESEARCH USE ONLY

苏州近岸蛋白质科技股份有限公司

品牌商

实名认证

钻石会员

入驻年限:13年

联系人:客服

地址:上海

电话联系

购买咨询

换一个